These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genetic detoxification of bacterial toxins: a new approach to vaccine development. Rappuoli R; Douce G; Dougan G; Pizza M Int Arch Allergy Immunol; 1995 Dec; 108(4):327-33. PubMed ID: 7580303 [TBL] [Abstract][Full Text] [Related]
5. [Recent advances in the molecular mechanism of action of bacterial toxins, in particular of diphtheria, cholera, coli, botulinum and shigella toxins as well as tetanospasmin and the toxins of staphylococcus aureus]. Kolb E Z Gesamte Inn Med; 1984 Mar; 39(6):85-92. PubMed ID: 6375175 [TBL] [Abstract][Full Text] [Related]
6. Medical aspects of biologic toxins. Marks JD Anesthesiol Clin North Am; 2004 Sep; 22(3):509-32, vii. PubMed ID: 15325716 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model. Reddy PN; Paul S; Sripathy MH; Batra HV Toxicon; 2015 Sep; 103():106-13. PubMed ID: 26091873 [TBL] [Abstract][Full Text] [Related]
9. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7. Padhye VV; Zhao T; Doyle MP J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749 [TBL] [Abstract][Full Text] [Related]
10. Role of exotoxins in bacterial pathogenicity. Arbuthnott JP J Appl Bacteriol; 1978 Jun; 44(3):329-45. PubMed ID: 97256 [No Abstract] [Full Text] [Related]
13. Cytotoxin CctA, a major virulence factor of Clostridium chauvoei conferring protective immunity against myonecrosis. Frey J; Johansson A; Bürki S; Vilei EM; Redhead K Vaccine; 2012 Aug; 30(37):5500-5. PubMed ID: 22749595 [TBL] [Abstract][Full Text] [Related]
14. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. Lemonnier M; Landraud L; Lemichez E FEMS Microbiol Rev; 2007 Sep; 31(5):515-34. PubMed ID: 17680807 [TBL] [Abstract][Full Text] [Related]
15. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin. Mantis NJ Adv Drug Deliv Rev; 2005 Jun; 57(9):1424-39. PubMed ID: 15935880 [TBL] [Abstract][Full Text] [Related]
16. Bacterial toxins. Lubran MM Ann Clin Lab Sci; 1988; 18(1):58-71. PubMed ID: 3281562 [TBL] [Abstract][Full Text] [Related]
17. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection. Cui JC; Hu DL; Lin YC; Qian AD; Nakane A FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222 [TBL] [Abstract][Full Text] [Related]
18. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins. Schlievert PM J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303 [TBL] [Abstract][Full Text] [Related]